Ibulocydine Is a Novel Prodrug Cdk Inhibitor That Effectively Induces Apoptosis in Hepatocellular Carcinoma Cells
Open Access
- 1 June 2011
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 286 (22), 19662-19671
- https://doi.org/10.1074/jbc.m110.209551
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- A New Classification of Prodrugs: Regulatory PerspectivesPharmaceuticals, 2009
- Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemiaBlood, 2009
- CDK inhibitors in cancer therapy: what is next?Trends in Pharmacological Sciences, 2008
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- The imbalance between Bim and Mcl‐1 expression controls the survival of human myeloma cellsEuropean Journal of Immunology, 2004
- Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavageOncogene, 2004
- Cyclin-dependent kinase inhibitor Roscovitine induces apoptosis in chronic lymphocytic leukemia cellsLeukemia, 2004
- IAP proteins: blocking the road to death's doorNature Reviews Molecular Cell Biology, 2002
- Lipase protein engineeringBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000
- Overexpression of the MDR1 Gene and P-Glycoprotein in Human Hepatocellular CarcinomaJNCI Journal of the National Cancer Institute, 1992